Mylan Gets More Sanofi Insulin Pen Patents Nixed At PTAB
Generic-drug maker Mylan convinced the Patent Trial and Appeal Board to nix a handful of Sanofi-Aventis patents Friday covering the Lantus SoloStar disposable insulin injection pen, adding to its past wins...To view the full article, register now.
Already a subscriber? Click here to view full article